SCHEMBL4392358

SCHEMBL4392358

O=C(OCO)N1CCCC(c2ccccc2)C1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 9/20 0.56
WDR77 Q9BQA1 9/20 0.56
ALDH1A1 P00352 4/20 0.54
LMNA P02545 1/20 0.54
HPGD P15428 1/20 0.54
HIF1A Q16665 1/20 0.54
POLB P06746 1/20 0.51
HSD11B1 P28845 2/20 0.50
BCL9 O00512 2/20 0.50
CTNNB1 P35222 2/20 0.50
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
GAA P10253 1/20 0.49
CYP2D6 P10635 1/20 0.49
MAPT P10636 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
HTT P42858 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21138877 0.89 ALDH1A1 (0.57) PRMT5WDR77ALDH1A1LMNAHPGD
SCHEMBL29087342 0.86 SMN1; SMN2 (0.59) PRMT5WDR77ALDH1A1LMNAHPGD
SCHEMBL4002382 0.84 CHRM4 (0.58) PRMT5WDR77ALDH1A1POLBHSD11B1
SCHEMBL31233182 0.81 ALDH1A1 (0.59) ALDH1A1LMNAHPGDHIF1APOLB
SCHEMBL27878990 0.80 ALDH1A1 (0.62) ALDH1A1LMNAHPGDHIF1APOLB
SCHEMBL3312540 0.80 ALDH1A1 (0.62) ALDH1A1LMNAHPGDHIF1APOLB
SCHEMBL6359096 0.79 ALDH1A1 (0.56) PRMT5ALDH1A1LMNAHPGDHIF1A
SCHEMBL21159622 0.79 BRD4 (0.61) ALDH1A1LMNAHPGDHIF1AHSD11B1
SCHEMBL31198901 0.78 PDE4B (0.54) PRMT5WDR77ALDH1A1POLBBCL9
SCHEMBL28351668 0.78 PRMT5 (0.60) PRMT5WDR77ALDH1A1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2077719-A2 PIPERIDINE AND PYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck and Co., Inc. (US) 2009-07-15 EP disclosed
WO-2008036316-A2 PIPERIDINE AND PYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2008-03-27 WO disclosed